Search

Your search keyword '"GLASS, LAUREN"' showing total 22 results
Start Over Author "GLASS, LAUREN"
22 results on '"GLASS, LAUREN"'

2. Expanding use of the HeartMate 3 ventricular assist device in pediatric and adult patients within the Advanced Cardiac Therapies Improving Outcomes Network (ACTION)

Author

O’Connor, Matthew J., Shezad, Muhammad, Ahmed, Humera, Amdani, Shahnawaz, Auerbach, Scott R., Bearl, David W., Butto, Arene, Byrnes, Jonathan W., Conway, Jennifer, Dykes, John C., Glass, Lauren, Lantz, Jodie, Law, Sabrina, Mongé, Michael C., Morales, David L.S., Parent, John J., Peng, David M., Ploutz, Michelle S., Puri, Kriti, Shugh, Svetlana, Shwaish, Natalie S., VanderPluym, Christina J., Wilkens, Sarah, Wright, Lydia, Zinn, Matthew D., and Lorts, Angela

Published
2023
Full Text
View/download PDF

3. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease

Author

Brothers, Matthew, Marino, Bradley, Canter, Charles, Law, Mark, Nguyen, Nguyenvu, Sang, Charlie, Shimano, Kristin, Gupta, Dipankar, Portman, Michael, Williams, Derek, Glass, Lauren, Sperrazza, Charles, Herold, Steven, Garg, Ruchira, Vranicar, Mark, Awad, Sawsan, Asante-Korang, Alfred, Druzgal, Colleen, Ozment, Caroline, Del Toro, Kamill, Roses, Ferran, Jux, Christian, Gravenhorst, Verena, Schweigmann, Ulrich, Bhatt, Mihir, Sabapathy, Christine, Dahdah, Nagib, Bartonicek, Dototea, Tulzer, Gerald, Basargina, Elena, Zvereva, Tatiana, Pertels, Tatiana, Plotnikova, Irina, Pierre-Emmanuel, S.E.G.U.E.L.A., Amedro, Pascal, Yves, Dulac, BONNET, Damien, Saraco, Paola, Rimini, Alessandro, Digtiar, Valerii, Gonchar, Margaryta, Kryuchko, Tetyana, Yablon, Olga, Bedi, Varinder Singh, Patel, Jashvant, Mitra, Monjori, Kusa, Jacek, Domagala, Kowalczyk, KÖRNYEI, László, BERECZKI, Csaba, ABLONCZY, László, Levitas, Vivianne Aviva, Mishali, David, Revel-Vilk, Shoshana, Harlev, Dan, Sasmaz, Hatice Ilgen, Ozbek, Namik Yasar, Unal, Sule, Patıroglu, Türkan, Malbora, Baris, Agin, Hasan, Karakas, Zeynep, Kavakli, Ramazan Kaan, Chalmers, Elizabeth, Bu'Lock, Frances, Daubeney, Piers, Hamza, Hala, Badr, Mohamed, Elalfy, Mohsen, Mansour, Ahmed, Hassab, Hoda, Sabry, Ayman, Daou, Linda, Bitar, Fadi, Portman, Michael A., Jacobs, Jeffrey P., Newburger, Jane W., Berger, Felix, Grosso, Michael A., Duggal, Anil, Tao, Ben, and Goldenberg, Neil A.

Published
2022
Full Text
View/download PDF

4. Successful explantation of children from the Berlin Heart EXCOR® ventricular assist device: A systematic review.

Author

Mikulski, Matthew F., Iyer, Swati, Well, Andrew, Mery, Carlos M., Owens, W. Richard, Glass, Lauren D., Castleberry, Chesney D., and Fraser, Charles D.

Subjects
HEART assist devices, CONGENITAL heart disease, MEDICAL equipment reliability, DILATED cardiomyopathy, HEART, HEART transplantation, PLANT micropropagation
Abstract

Background: The Berlin Heart EXCOR® (BHE) can bridge children with severe heart failure to transplantation, but some are successfully weaned and spared transplantation. This study seeks to identify characteristics of children amenable to successful explantation with BHE support. Methods: Preferred Reporting Items for Systematic reviews and Meta‐Analyses 2020 guidelines were used. Five databases were screened for original, English articles measuring BHE support in patients <18 years old based on title and abstract. Exclusion criteria were applied: full‐text availability, <10 total pediatric BHE patients, zero successful explantations from BHE, nonprimary literature, adult and pediatric results that could not be separated, and studies with overlapping patient information. Studies were analyzed with descriptive statistics. Results: From 41 857 potential studies, 14 were analyzed with data from 58 hospitals on four continents from 1990 to 2020. There were 984 BHE patients. The most common diagnosis was dilated cardiomyopathy (n = 318, 32.3%), followed by congenital heart disease (n = 249, 25.3%). There were 85 (8.6%) children explanted with favorable outcomes. The underlying diagnosis was known in 44 (51.8%) cases: 14 (8.4%) of 166 cardiomyopathies, 17 (48.6%) of 35 myocarditis, and 12 (16.7%) of 72 with congenital heart disease were explanted. When the type of support was known, the rate of LVAD patients explanted was 21.3% (n = 19/89) and 2.4% (n = 1/42) of BiVAD patients were explanted. Conclusion: Explantation from BHE is not uncommon at 8.6%, but significant variation exists in the explantation data reported. Myocarditis and LVAD support may be populations suitable for weaning. Standardization of reporting measures and prospective registries may help identify patients suitable for this alternative to transplant and help develop weaning protocols. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

5. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease

Author

Portman, Michael A., primary, Jacobs, Jeffrey P., additional, Newburger, Jane W., additional, Berger, Felix, additional, Grosso, Michael A., additional, Duggal, Anil, additional, Tao, Ben, additional, Goldenberg, Neil A., additional, Brothers, Matthew, additional, Marino, Bradley, additional, Canter, Charles, additional, Law, Mark, additional, Nguyen, Nguyenvu, additional, Sang, Charlie, additional, Shimano, Kristin, additional, Gupta, Dipankar, additional, Portman, Michael, additional, Williams, Derek, additional, Glass, Lauren, additional, Sperrazza, Charles, additional, Herold, Steven, additional, Garg, Ruchira, additional, Vranicar, Mark, additional, Awad, Sawsan, additional, Asante-Korang, Alfred, additional, Druzgal, Colleen, additional, Ozment, Caroline, additional, Del Toro, Kamill, additional, Roses, Ferran, additional, Jux, Christian, additional, Gravenhorst, Verena, additional, Schweigmann, Ulrich, additional, Bhatt, Mihir, additional, Sabapathy, Christine, additional, Dahdah, Nagib, additional, Bartonicek, Dototea, additional, Tulzer, Gerald, additional, Basargina, Elena, additional, Zvereva, Tatiana, additional, Pertels, Tatiana, additional, Plotnikova, Irina, additional, Pierre-Emmanuel, S.E.G.U.E.L.A., additional, Amedro, Pascal, additional, Yves, Dulac, additional, BONNET, Damien, additional, Saraco, Paola, additional, Rimini, Alessandro, additional, Digtiar, Valerii, additional, Gonchar, Margaryta, additional, Kryuchko, Tetyana, additional, Yablon, Olga, additional, Bedi, Varinder Singh, additional, Patel, Jashvant, additional, Mitra, Monjori, additional, Kusa, Jacek, additional, Domagala, Kowalczyk, additional, KÖRNYEI, László, additional, BERECZKI, Csaba, additional, ABLONCZY, László, additional, Levitas, Vivianne Aviva, additional, Mishali, David, additional, Revel-Vilk, Shoshana, additional, Harlev, Dan, additional, Sasmaz, Hatice Ilgen, additional, Ozbek, Namik Yasar, additional, Unal, Sule, additional, Patıroglu, Türkan, additional, Malbora, Baris, additional, Agin, Hasan, additional, Karakas, Zeynep, additional, Kavakli, Ramazan Kaan, additional, Chalmers, Elizabeth, additional, Bu'Lock, Frances, additional, Daubeney, Piers, additional, Hamza, Hala, additional, Badr, Mohamed, additional, Elalfy, Mohsen, additional, Mansour, Ahmed, additional, Hassab, Hoda, additional, Sabry, Ayman, additional, Daou, Linda, additional, and Bitar, Fadi, additional

Published
2022
Full Text
View/download PDF

8. Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients Does Early-Onset Portend a Worse Prognosis?

Author

Khoury, Michael, primary, Conway, Jennifer, additional, Gossett, Jeffrey G, additional, Edens, Erik, additional, Soto, Stephanie, additional, Cantor, Ryan, additional, Koehl, Devin, additional, Barnes, Aliessa, additional, Exil, Vernat, additional, Glass, Lauren, additional, Kirklin, James K., additional, and Zuckerman, Warren A., additional

Published
2022
Full Text
View/download PDF

10. sj-pdf-1-qhr-10.1177_10497323211041109 – Supplemental material for Gossip and Addiction Recovery in Rural Communities

Author

Krentzman, Amy R. and Glass, Lauren K.

Subjects
111099 Nursing not elsewhere classified, 111799 Public Health and Health Services not elsewhere classified, 160807 Sociological Methodology and Research Methods, FOS: Health sciences, FOS: Sociology
Abstract

Supplemental material, sj-pdf-1-qhr-10.1177_10497323211041109 for Gossip and Addiction Recovery in Rural Communities by Amy R. Krentzman and Lauren K. Glass in Qualitative Health Research

Published
2021
Full Text
View/download PDF

11. sj-pdf-2-qhr-10.1177_10497323211041109 – Supplemental material for Gossip and Addiction Recovery in Rural Communities

Author

Krentzman, Amy R. and Glass, Lauren K.

Subjects
111099 Nursing not elsewhere classified, 111799 Public Health and Health Services not elsewhere classified, 160807 Sociological Methodology and Research Methods, FOS: Health sciences, FOS: Sociology
Abstract

Supplemental material, sj-pdf-2-qhr-10.1177_10497323211041109 for Gossip and Addiction Recovery in Rural Communities by Amy R. Krentzman and Lauren K. Glass in Qualitative Health Research

Published
2021
Full Text
View/download PDF

13. Fontan‐associated plastic bronchitis waitlist and heart transplant outcomes: A PHTS analysis

Author

Bearl, David W., primary, Cantor, Ryan, additional, Koehl, Devin, additional, Gossett, Jeffrey G., additional, Bock, Matthew J., additional, Halnon, Nancy, additional, Glass, Lauren, additional, Exil, Vernat, additional, Musselwhite, Courtney, additional, Kirklin, James K., additional, Godown, Justin, additional, and Ravishankar, Chitra, additional

Published
2021
Full Text
View/download PDF

19. An Investigation of the Meaning of Death for Hegelian Spirit.

Author

Glass, Lauren

Subjects
SPIRIT, DEATH, HEGELIANISM
Abstract

This work explores the paradoxical necessity of death for the actuality and purposiveness of Hegelian Spirit, i.e., collective and particular self. I defend an interpretation that illustrates death as the precondition for development, and thus significance, for Spirit. My central claim is supported by the placement of Hegel's discussion of death within the Phenomenology of Spirit and is consistent with interpretations by Alexandre Kojève and Georges Bataille. The dual manifestation of death as potentiality and actuality is examined and lends insight to the stepwise evolution of Spirit. [ABSTRACT FROM AUTHOR]

Published
2016

21. NETWORK LIKE A PRO.

Author

GLASS, LAUREN

Subjects
SOCIAL networks, DEMOGRAPHIC surveys
Published
2019

22. Expanding use of the HeartMate 3 ventricular assist device in pediatric and adult patients within the Advanced Cardiac Therapies Improving Outcomes Network (ACTION).

Author

O'Connor, Matthew J., Shezad, Muhammad, Ahmed, Humera, Amdani, Shahnawaz, Auerbach, Scott R., Bearl, David W., Butto, Arene, Byrnes, Jonathan W., Conway, Jennifer, Dykes, John C., Glass, Lauren, Lantz, Jodie, Law, Sabrina, Mongé, Michael C., Morales, David L.S., Parent, John J., Peng, David M., Ploutz, Michelle S., Puri, Kriti, and Shugh, Svetlana

Subjects
*HEART assist devices, *CHILD patients, *HEMORRHAGIC stroke, *BODY surface area, *ISCHEMIC stroke, *DILATED cardiomyopathy
Abstract

We report current outcomes in patients supported with the HeartMate 3 (HM3) ventricular assist device in a multicenter learning network. The Advanced Cardiac Therapies Improving Outcomes Network database was queried for HM3 implants between 12/2017 and 5/2022. Clinical characteristics, postimplant course, and adverse events were collected. Patients were stratified according to body surface area (BSA) (<1.4 m2, 1.4-1.8 m2, and >1.8 m2) at device implantation. During the study period, 170 patients were implanted with the HM3 at participating network centers, with median age 15.3 years; 27.1% were female. Median BSA was 1.68 m2; the smallest patient was 0.73 m2 (17.7 kg). Most (71.8%) had a diagnosis of dilated cardiomyopathy. With a median support time of 102.5 days, 61.2% underwent transplantation, 22.9% remained supported on device, 7.6% died, and 2.4% underwent device explantation for recovery; the remainder had transferred to another institution or transitioned to a different device type. The most common adverse events included major bleeding (20.8%) and driveline infection (12.9%); ischemic and hemorrhagic stroke were encountered in 6.5% and 1.2% of patients, respectively. Patients with BSA <1.4 m2 had a higher incidence of infection, renal dysfunction, and ischemic stroke. In this updated cohort of predominantly pediatric patients supported with the HM3 ventricular assist device, outcomes are excellent with <8% mortality on device. Device-related adverse events including stroke, infection, and renal dysfunction were more commonly seen in smaller patients, highlighting opportunities for improvements in care. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results